Role of the cannabinoid system in the effects induced
by nicotine on anxiety-like behaviour in mice
by
Balerio GN, Aso E, Maldonado R.
Laboratori de Neurofarmacologia,
Facultat de Ciencies de la Salut i de la Vida,
Universitat Pompeu Fabra,
C/ Doctor Aiguader 80, 08003, Barcelona, Spain,
rafael.maldonado@upf.edu.
Psychopharmacology (Berl). 2006 Jan 14;:1-10

ABSTRACT

RATIONALE: Acute behavioural effects and motivational responses induced by nicotine can be modulated by the endocannabinoid system supporting the existence of a physiological interaction between these two systems. OBJECTIVES: The present study was designed to examine the possible involvement of the cannabinoid system in the anxiolytic- and anxiogenic-like responses induced by nicotine in mice. METHODS: Animals were only exposed once to nicotine. The acute administration of low (0.05) or high (0.8 mg/kg, s.c.) doses of nicotine produced opposite effects in the elevated plus-maze, i.e. anxiolytic- and anxiogenic-like responses, respectively. The effects of the pretreatment with the CB1 cannabinoid receptor antagonist, rimonabant (0.25, 0.5 and 1 mg/kg, i.p.), and the cannabinoid agonist, Delta9-tetrahydrocannabinol (Delta9-THC, 0.1 mg/kg, ip), were evaluated on the anxiolytic- and anxiogenic-like responses induced by nicotine. RESULTS: Rimonabant completely abolished nicotine-induced anxiolytic-like effects and increased the anxiogenic-like responses of nicotine, suggesting an involvement of CB1 receptors in these behavioural responses. On the other hand, Delta9-THC failed to modify nicotine anxiolytic-like responses but attenuated its anxiogenic-like effects. In addition, the association of non-effective doses of Delta9-THC and nicotine produced clear anxiolytic-like responses. CONCLUSIONS: These results demonstrate that the endogenous cannabinoid system is involved in the regulation of nicotine anxiety-like behaviour in mice and provide new findings to support the use of cannabinoid antagonists in the treatment of tobacco addiction.

Nicotine
Tobacco
Smoking
Cotinine
Selegiline
Dopamine
Cigarettes
Cannabinoids
Free-base nicotine
Nicotine : structure
Parkinson's disease
Smoking and MAO-A
Smoking and MAO-B
Nicotine neuroprotection
Nicotine, dopamine and reward
Muscarinic + nicotinic receptors
Nicotine and the dopamine d3 receptors
Tranylcypromine (Parnate) and nicotine
Nicotine, pleasure, and reward sensitization
Quitting smoking: the role of antidepressants

Refs
and further reading

HOME
HedWeb
Nootropics
cocaine.wiki
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family